{"id":5806,"date":"2024-01-12T13:21:23","date_gmt":"2024-01-12T12:21:23","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/?post_type=congress&#038;p=5806"},"modified":"2024-04-09T15:12:35","modified_gmt":"2024-04-09T14:12:35","slug":"esh-cll-2024","status":"publish","type":"congress","link":"http:\/\/beonemedaffairs.com\/begenius\/congress\/5806\/esh-cll-2024\/","title":{"rendered":"ESH CLL 2024"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"editor_notices":[]},"specialisation":[],"class_list":["post-5806","congress","type-congress","status-publish","hentry","congress_category-congress"],"acf":{"show_in_cards":false,"show_in_filter":false,"visible_for_guests":false,"show_popup":true,"acronym":"ESH CLL","title":"","sub-heading-override":"","congress_type":"Congress","start_date":"2024-03-08T00:00:00+00:00","end_date":"2024-03-10T00:00:00+00:00","location":"Vienna, Austria","extra_flag":"","deactivated":false,"alternate_button_text":"","tag":false,"content_block":[{"content_block_title":"Did you miss us at the ESH 3rd Translational Research Conference: Chronic Lymphocytic Leukaemia?","content_block_text":"If so, you can chat with a member of our team by clicking the \u2018Chat with BeiGene\u2019 icon.","content_block_image":""},{"content_block_title":"Did you attend our Satellite Symposium: New avenues to improving outcomes for CLL patients?","content_block_text":"If not, you are lucky, you can view the webcast of the Satellite Symposium <strong><a href=\"https:\/\/beonemedaffairs.com\/6224\/satellite-symposium-new-avenues-to-improving-outcomes-for-cll-patients\/\">here<\/a><\/strong>.\r\n\r\nThe Satellite Symposium, titled \u2018New avenues to improving outcomes for CLL patients\u2019, provided an overview of BTK inhibitors in TN and R\/R CLL, with a focus on biomarkers and treatment selection. The experts discussed BTK mutation data and ways to overcome resistance to current CLL treatments. New translational data and latest results from the German Richter\u2019s transformation RT1 study were also presented.","content_block_image":5868}],"ics_file":"http:\/\/beonemedaffairs.com\/begenius\/wp-content\/uploads\/sites\/30\/2024\/01\/ESH-CLL-2024.ics","summary":"European School of Haematology - Chronic Lymphocytic Leukemia","related":"","field_page_schema_override":null,"field_show_asset_alt":false},"_links":{"self":[{"href":"http:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/congress\/5806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/congress"}],"about":[{"href":"http:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/types\/congress"}],"wp:attachment":[{"href":"http:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/media?parent=5806"}],"wp:term":[{"taxonomy":"specialisation","embeddable":true,"href":"http:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/specialisation?post=5806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}